{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:41:11Z","timestamp":1790764871552,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1177\/2168479014567317","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T22:19:54Z","timestamp":1424211594000},"page":"584-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Choosing Appropriate Estimands in Clinical Trials"],"prefix":"10.1007","volume":"49","author":[{"given":"Ann-Kristin","family":"Leuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Zinserling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Benda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"49040584_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139381666","volume-title":"Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practical Guide","author":"CH Mallinckrodt","year":"2013","unstructured":"Mallinckrodt CH. Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practical Guide. New York: Cambridge University Press; 2013."},{"key":"49040584_CR2","volume-title":"The Prevention and Treatment of Missing Data in Clinical Trials","author":"National Research Council: Panel on Handling Missing Data in Clinical Trials.","year":"2010","unstructured":"National Research Council: Panel on Handling Missing Data in Clinical Trials. The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: National Academies Press; 2010."},{"key":"49040584_CR3","volume-title":"Statistical Analysis With Missing Data","author":"RJA Little","year":"1987","unstructured":"Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York: John Wiley & Sons; 1987."},{"key":"49040584_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/9780470510445","volume-title":"Missing Data in Clinical Studies","author":"G Molenberghs","year":"2007","unstructured":"Molenberghs G, Kenward MG. Missing Data in Clinical Studies. New York: John Wiley & Sons; 2007."},{"key":"49040584_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/009286150904300404","volume":"43","author":"G Molenberghs","year":"2009","unstructured":"Molenberghs G. Incomplete data in clinical studies: analysis, sensitivity, and sensitivity analysis. Drug Inf J. 2009;43:409\u2013429.","journal-title":"Drug Inf J"},{"key":"49040584_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/9781119942283","volume-title":"Multiple Imputation and Its Application","author":"JR Carpenter","year":"2013","unstructured":"Carpenter JR, Kenward MG. Multiple Imputation and Its Application. New York: John Wiley & Sons; 2013."},{"key":"49040584_CR7","unstructured":"International Conference on Harmonisation. Statistical Principles for Clinical Trials E9: 1998. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E9\/Step4\/E9_Guideline.pdf. Accessed February 2014"},{"key":"49040584_CR8","unstructured":"European Medicines Agency. EMA\/CPMP\/EWP\/1776\/99 Rev. 1 Guideline on Missing Data in Confirmatory Clinical Trials. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/09\/WC500096793.pdf. Published 2011. Accessed June 2013"},{"key":"49040584_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/2168479013501310","volume":"48","author":"CH Mallinckrodt","year":"2014","unstructured":"Mallinckrodt CH, Roger J, Chuang-Stein C, et al. Recent developments in the prevention and treatment of missing data. Therapeutic Innovation & Regulatory Science. 2014;48:68\u201380.","journal-title":"Therapeutic Innovation & Regulatory Science"},{"key":"49040584_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/clpt.2011.340","volume":"91","author":"RT O\u2019Neill","year":"2012","unstructured":"O\u2019Neill RT, Temple R. The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it. Clin Pharmacol Ther. 2012;91:550\u2013554.","journal-title":"Clin Pharmacol Ther"},{"key":"49040584_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4155\/cli.13.7","volume":"3","author":"MG Kenward","year":"2013","unstructured":"Kenward MG. The handling of missing data in clinical trials. Clin Invest. 2013;3:241\u2013250.","journal-title":"Clin Invest"},{"key":"49040584_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/009286150904300410","volume":"43","author":"CH Mallinckrodt","year":"2009","unstructured":"Mallinckrodt CH, Kenward MG. Conceptual considerations regarding endpoints, hypotheses, and analyses for incomplete longitudinal clinical trial data. Drug Inf J. 2009;43:449\u2013458.","journal-title":"Drug Inf J"},{"key":"49040584_CR13","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1080\/10543406.2013.834911","volume":"23","author":"JR Carpenter","year":"2013","unstructured":"Carpenter JR, Roger JH, Kenward MG. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation. J Biopharm Stat. 2013;23:1352\u20131371.","journal-title":"J Biopharm Stat"},{"key":"49040584_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/pst.1536","volume":"11","author":"CH Mallinckrodt","year":"2012","unstructured":"Mallinckrodt CH, Lin Q, Lipkovich I, Molenberghs G. A structural approach to choosing estimands and estimators in longitudinal clinical trials. Pharm Stat. 2012;11:456\u2013461.","journal-title":"Pharm Stat"},{"key":"49040584_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7326\/0003-4819-154-2-201101180-00010","volume":"154","author":"TR Fleming","year":"2011","unstructured":"Fleming TR. Addressing missing data in clinical trials. Ann Internal Med. 2011;154:113\u2013117.","journal-title":"Ann Internal Med"},{"key":"49040584_CR16","unstructured":"European Medicines Agency. CPMP\/EWP\/1080\/00 Rev. 1 Guideline on Clinical Investigation of Medicinal Products in the Treatment or Prevention of Diabetes Mellitus. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2012\/06\/WC500129256.pdf. Published 2012. Accessed February 2014."},{"key":"49040584_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archpsyc.1993.01820210073009","volume":"50","author":"RD Gibbons","year":"1993","unstructured":"Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry. 1993;50:739\u2013750.","journal-title":"Arch Gen Psychiatry"},{"key":"49040584_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/009286150103500418","volume":"35","author":"CH Mallinckrodt","year":"2001","unstructured":"Mallinckrodt CH, Clark WS, David SR. Type 1 error rates from mixed effects model repeated measures versus fixed effects ANOVA with missing values imputed via last observation carried forward. Drug Inf J. 2001;35:1215\u20131225.","journal-title":"Drug Inf J"},{"key":"49040584_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1081\/BIP-120019265","volume":"13","author":"CH Mallinckrodt","year":"2003","unstructured":"Mallinckrodt CH, Clark SW, Carroll RJ, Molenberghs G. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations. J Biopharm Stat. 2003;13:179\u2013190.","journal-title":"J Biopharm Stat"},{"key":"49040584_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1191\/1740774504cn049oa","volume":"1","author":"CH Mallinckrodt","year":"2004","unstructured":"Mallinckrodt CH, Kaiser CJ, Watkin JG, Molenberghs G, Carroll RJ. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA. Clin Trials. 2004;1:477\u2013489.","journal-title":"Clin Trials"},{"key":"49040584_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0006-3223(02)01867-X","volume":"53","author":"CH Mallinckrodt","year":"2003","unstructured":"Mallinckrodt CH, Sanger TM, Dube S, et al. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry. 2003;53:754\u2013760.","journal-title":"Biol Psychiatry"},{"key":"49040584_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/biostatistics\/kxh001","volume":"5","author":"G Molenberghs","year":"2004","unstructured":"Molenberghs G, Thijs H, Jansen I, et al. Analyzing incomplete longitudinal clinical trial data. Biostatistics. 2004;5:445\u2013464.","journal-title":"Biostatistics"},{"key":"49040584_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/009286150804200402","volume":"42","author":"CH Mallinckrodt","year":"2007","unstructured":"Mallinckrodt CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Drug Inf J. 2007;42:303\u2013319.","journal-title":"Drug Inf J"},{"key":"49040584_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/10543406.2013.859148","volume":"24","author":"B Teshome","year":"2014","unstructured":"Teshome B, Lipkovich I, Molenberghs G, Mallinckrodt CH. A multiple-imputation-based approach to sensitivity analyses and effectiveness assessments in longitudinal clinical trials. J Biopharm Stat. 2014;24:211\u2013228.","journal-title":"J Biopharm Stat"},{"key":"49040584_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/pst.1549","volume":"12","author":"B Ratitch","year":"2013","unstructured":"Ratitch B, O\u2019Kelly M, Tosiello R. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models. Pharm Stat. 2013;12:337\u2013347.","journal-title":"Pharm Stat"},{"key":"49040584_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2307\/2532847","volume":"52","author":"RJA Little","year":"1996","unstructured":"Little RJA, Yau L. Intention-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996;52:1324\u20131333.","journal-title":"Biometrics"},{"key":"49040584_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/sim.5924","volume":"33","author":"AK Leuchs","year":"2014","unstructured":"Leuchs AK, Zinserling J, Schlosser-Weber G, Berres M, Neuh\u00e4user M, Benda N. Estimation of the treatment effect in the presence of non-compliance and missing data. Stat Med. 2014;33:193\u2013208.","journal-title":"Stat Med"},{"key":"49040584_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/009286151004400312","volume":"44","author":"N Benda","year":"2010","unstructured":"Benda N, Branson M, Maurer W, Friede T. Aspects of modernizing drug development using clinical scenario planning and evaluation. Drug Inf J. 2010;44:297\u2013315.","journal-title":"Drug Inf J"},{"key":"49040584_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pst.1547","volume":"12","author":"CH Mallinckrodt","year":"2013","unstructured":"Mallinckrodt CH, Lin Q, Molenberghs G. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials. Pharm Stat. 2013;12:1\u20136.","journal-title":"Pharm Stat"},{"key":"49040584_CR30","unstructured":"European Medicines Agency. EMA\/CHMP\/185423\/2010, Rev 2 Previously (CPMP\/EWP\/518\/97, Rev. 1) Guideline on Clinical Investigation of Medicinal Products in the Treatment of Depression. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/05\/WC500143770.pdf. Published 2013. Accessed June 2014."},{"key":"49040584_CR31","unstructured":"European Medicines Agency. EMA\/CHMP\/623942\/2013 Guideline on Clinical Investigation of Medicinal Products for Prevention of Stroke and Systemic Embolic Events in Patients With Non-valvular Atrial Fibrillation. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/11\/WC500154227.pdf. Published 2013. Accessed June 2014."},{"key":"49040584_CR32","unstructured":"O\u2019Kelly M, Lipkovich I. Using multiple imputation and delta adjustment to implement sensitivity analyses for time-to-event data. Presentation at: PSI 2014 conference; May 11\u201314, 2014; London."}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479014567317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2168479014567317","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1177\/2168479014567317\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2168479014567317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479014567317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T08:52:52Z","timestamp":1597999972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1177\/2168479014567317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["49040584"],"URL":"https:\/\/doi.org\/10.1177\/2168479014567317","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725401621.793505299","asserted-by":"object"}]},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"26 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}